Gabriel Lopez-Berestein
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Molecular Biology, OncologyGoogle:
"Gabriel Lopez-Berestein"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Szymanowski W, Szymanowska A, Bielawska A, et al. (2023) Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. Cancers. 15 |
Dasari SK, Joseph R, Umamaheswaran S, et al. (2023) Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. International Journal of Molecular Sciences. 24 |
Noh K, Bach DH, Choi HJ, et al. (2020) The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis. Oncogene |
Elsayed AM, Amero P, Salama SA, et al. (2020) Back to the Future: Rethinking the Great Potential of lncRNA for Optimizing Chemotherapeutic Response in Ovarian Cancer. Cancers. 12 |
Lara OD, Bayraktar E, Amero P, et al. (2020) Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer. Oncotarget. 11: 2819-2833 |
Miyake TM, Pradeep S, Bayraktar E, et al. (2020) NRG1/ERBB3 pathway activation induces acquired resistance to XPO1 inhibitors. Molecular Cancer Therapeutics |
Attia YM, Shouman SA, Salama SA, et al. (2020) Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer. International Journal of Molecular Sciences. 21 |
Kanlikilicer P, Bayraktar R, Denizli M, et al. (2020) Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]. Ebiomedicine. 52: 102630 |
El-Arabey AA, Denizli M, Kanlikilicer P, et al. (2020) GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cellular Signalling. 109539 |
Ma S, Mangala LS, Hu W, et al. (2020) Abstract 6331: Cloaking VEGF in small extracellular vesicles as a cause of adaptive resistance to anti-VEGF therapy Cancer Research. 80: 6331-6331 |